Capital Asset Pricing Model (CAPM)
Capital asset pricing model (CAPM) indicates what should be the expected or required rate of return on risky assets like Allergan Inc. common stock.
Paying user area
Try for free
Allergan Inc. pages available for free this week:
- Balance Sheet: Liabilities and Stockholders’ Equity
- Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
- Analysis of Short-term (Operating) Activity Ratios
- Analysis of Long-term (Investment) Activity Ratios
- Analysis of Reportable Segments
- Enterprise Value (EV)
- Enterprise Value to EBITDA (EV/EBITDA)
- Dividend Discount Model (DDM)
- Present Value of Free Cash Flow to Equity (FCFE)
- Analysis of Debt
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Allergan Inc. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Rates of Return
Allergan Inc., monthly rates of return
| Allergan Inc. (AGN.) | Standard & Poor’s 500 (S&P 500) | |||||
|---|---|---|---|---|---|---|
| t | Date | PriceAGN.,t1 | DividendAGN.,t1 | RAGN.,t2 | PriceS&P 500,t | RS&P 500,t3 |
| Jan 31, 2010 | ||||||
| 1. | Feb 28, 2010 | |||||
| 2. | Mar 31, 2010 | |||||
| 3. | Apr 30, 2010 | |||||
| . | . | . | . | . | . | . |
| . | . | . | . | . | . | . |
| . | . | . | . | . | . | . |
| 58. | Nov 30, 2014 | |||||
| 59. | Dec 31, 2014 | |||||
| Average (R): | ||||||
| Standard deviation: | ||||||
| Allergan Inc. (AGN.) | Standard & Poor’s 500 (S&P 500) | |||||
|---|---|---|---|---|---|---|
| t | Date | PriceAGN.,t1 | DividendAGN.,t1 | RAGN.,t2 | PriceS&P 500,t | RS&P 500,t3 |
| Jan 31, 2010 | ||||||
| 1. | Feb 28, 2010 | |||||
| 2. | Mar 31, 2010 | |||||
| 3. | Apr 30, 2010 | |||||
| 4. | May 31, 2010 | |||||
| 5. | Jun 30, 2010 | |||||
| 6. | Jul 31, 2010 | |||||
| 7. | Aug 31, 2010 | |||||
| 8. | Sep 30, 2010 | |||||
| 9. | Oct 31, 2010 | |||||
| 10. | Nov 30, 2010 | |||||
| 11. | Dec 31, 2010 | |||||
| 12. | Jan 31, 2011 | |||||
| 13. | Feb 28, 2011 | |||||
| 14. | Mar 31, 2011 | |||||
| 15. | Apr 30, 2011 | |||||
| 16. | May 31, 2011 | |||||
| 17. | Jun 30, 2011 | |||||
| 18. | Jul 31, 2011 | |||||
| 19. | Aug 31, 2011 | |||||
| 20. | Sep 30, 2011 | |||||
| 21. | Oct 31, 2011 | |||||
| 22. | Nov 30, 2011 | |||||
| 23. | Dec 31, 2011 | |||||
| 24. | Jan 31, 2012 | |||||
| 25. | Feb 29, 2012 | |||||
| 26. | Mar 31, 2012 | |||||
| 27. | Apr 30, 2012 | |||||
| 28. | May 31, 2012 | |||||
| 29. | Jun 30, 2012 | |||||
| 30. | Jul 31, 2012 | |||||
| 31. | Aug 31, 2012 | |||||
| 32. | Sep 30, 2012 | |||||
| 33. | Oct 31, 2012 | |||||
| 34. | Nov 30, 2012 | |||||
| 35. | Dec 31, 2012 | |||||
| 36. | Jan 31, 2013 | |||||
| 37. | Feb 28, 2013 | |||||
| 38. | Mar 31, 2013 | |||||
| 39. | Apr 30, 2013 | |||||
| 40. | May 31, 2013 | |||||
| 41. | Jun 30, 2013 | |||||
| 42. | Jul 31, 2013 | |||||
| 43. | Aug 31, 2013 | |||||
| 44. | Sep 30, 2013 | |||||
| 45. | Oct 31, 2013 | |||||
| 46. | Nov 30, 2013 | |||||
| 47. | Dec 31, 2013 | |||||
| 48. | Jan 31, 2014 | |||||
| 49. | Feb 28, 2014 | |||||
| 50. | Mar 31, 2014 | |||||
| 51. | Apr 30, 2014 | |||||
| 52. | May 31, 2014 | |||||
| 53. | Jun 30, 2014 | |||||
| 54. | Jul 31, 2014 | |||||
| 55. | Aug 31, 2014 | |||||
| 56. | Sep 30, 2014 | |||||
| 57. | Oct 31, 2014 | |||||
| 58. | Nov 30, 2014 | |||||
| 59. | Dec 31, 2014 | |||||
| Average (R): | ||||||
| Standard deviation: | ||||||
Show all
1 Data in US$ per share of common stock, adjusted for splits and stock dividends.
2 Rate of return on common stock of AGN. during period t
3 Rate of return on S&P 500 (the market portfolio proxy) during period t
Variance and Covariance
Allergan Inc., calculation of variance and covariance of returns
| t | Date | RAGN.,t | RS&P 500,t | (RAGN.,t–RAGN.)2 | (RS&P 500,t–RS&P 500)2 | (RAGN.,t–RAGN.)×(RS&P 500,t–RS&P 500) |
|---|---|---|---|---|---|---|
| 1. | Feb 28, 2010 | |||||
| 2. | Mar 31, 2010 | |||||
| 3. | Apr 30, 2010 | |||||
| . | . | . | . | . | . | . |
| . | . | . | . | . | . | . |
| . | . | . | . | . | . | . |
| 58. | Nov 30, 2014 | |||||
| 59. | Dec 31, 2014 | |||||
| Total (Σ): | ||||||
| t | Date | RAGN.,t | RS&P 500,t | (RAGN.,t–RAGN.)2 | (RS&P 500,t–RS&P 500)2 | (RAGN.,t–RAGN.)×(RS&P 500,t–RS&P 500) |
|---|---|---|---|---|---|---|
| 1. | Feb 28, 2010 | |||||
| 2. | Mar 31, 2010 | |||||
| 3. | Apr 30, 2010 | |||||
| 4. | May 31, 2010 | |||||
| 5. | Jun 30, 2010 | |||||
| 6. | Jul 31, 2010 | |||||
| 7. | Aug 31, 2010 | |||||
| 8. | Sep 30, 2010 | |||||
| 9. | Oct 31, 2010 | |||||
| 10. | Nov 30, 2010 | |||||
| 11. | Dec 31, 2010 | |||||
| 12. | Jan 31, 2011 | |||||
| 13. | Feb 28, 2011 | |||||
| 14. | Mar 31, 2011 | |||||
| 15. | Apr 30, 2011 | |||||
| 16. | May 31, 2011 | |||||
| 17. | Jun 30, 2011 | |||||
| 18. | Jul 31, 2011 | |||||
| 19. | Aug 31, 2011 | |||||
| 20. | Sep 30, 2011 | |||||
| 21. | Oct 31, 2011 | |||||
| 22. | Nov 30, 2011 | |||||
| 23. | Dec 31, 2011 | |||||
| 24. | Jan 31, 2012 | |||||
| 25. | Feb 29, 2012 | |||||
| 26. | Mar 31, 2012 | |||||
| 27. | Apr 30, 2012 | |||||
| 28. | May 31, 2012 | |||||
| 29. | Jun 30, 2012 | |||||
| 30. | Jul 31, 2012 | |||||
| 31. | Aug 31, 2012 | |||||
| 32. | Sep 30, 2012 | |||||
| 33. | Oct 31, 2012 | |||||
| 34. | Nov 30, 2012 | |||||
| 35. | Dec 31, 2012 | |||||
| 36. | Jan 31, 2013 | |||||
| 37. | Feb 28, 2013 | |||||
| 38. | Mar 31, 2013 | |||||
| 39. | Apr 30, 2013 | |||||
| 40. | May 31, 2013 | |||||
| 41. | Jun 30, 2013 | |||||
| 42. | Jul 31, 2013 | |||||
| 43. | Aug 31, 2013 | |||||
| 44. | Sep 30, 2013 | |||||
| 45. | Oct 31, 2013 | |||||
| 46. | Nov 30, 2013 | |||||
| 47. | Dec 31, 2013 | |||||
| 48. | Jan 31, 2014 | |||||
| 49. | Feb 28, 2014 | |||||
| 50. | Mar 31, 2014 | |||||
| 51. | Apr 30, 2014 | |||||
| 52. | May 31, 2014 | |||||
| 53. | Jun 30, 2014 | |||||
| 54. | Jul 31, 2014 | |||||
| 55. | Aug 31, 2014 | |||||
| 56. | Sep 30, 2014 | |||||
| 57. | Oct 31, 2014 | |||||
| 58. | Nov 30, 2014 | |||||
| 59. | Dec 31, 2014 | |||||
| Total (Σ): | ||||||
Show all
VarianceAGN. = Σ(RAGN.,t–RAGN.)2 ÷ (59 – 1)
= ÷ (59 – 1)
=
VarianceS&P 500 = Σ(RS&P 500,t–RS&P 500)2 ÷ (59 – 1)
= ÷ (59 – 1)
=
CovarianceAGN., S&P 500 = Σ(RAGN.,t–RAGN.)×(RS&P 500,t–RS&P 500) ÷ (59 – 1)
= ÷ (59 – 1)
=
Systematic Risk (β) Estimation
| VarianceAGN. | |
| VarianceS&P 500 | |
| CovarianceAGN., S&P 500 | |
| Correlation coefficientAGN., S&P 5001 | |
| βAGN.2 | |
| αAGN.3 |
Calculations
1 Correlation coefficientAGN., S&P 500
= CovarianceAGN., S&P 500 ÷ (Standard deviationAGN. × Standard deviationS&P 500)
= ÷ ( × )
=
2 βAGN.
= CovarianceAGN., S&P 500 ÷ VarianceS&P 500
= ÷
=
3 αAGN.
= AverageAGN. – βAGN. × AverageS&P 500
= – ×
=
Expected Rate of Return
| Assumptions | ||
| Rate of return on LT Treasury Composite1 | RF | |
| Expected rate of return on market portfolio2 | E(RM) | |
| Systematic risk (β) of Allergan Inc. common stock | βAGN. | |
| Expected rate of return on Allergan Inc. common stock3 | E(RAGN.) | |
1 Unweighted average of bid yields on all outstanding fixed-coupon U.S. Treasury bonds neither due or callable in less than 10 years (risk-free rate of return proxy).
3 E(RAGN.) = RF + βAGN. [E(RM) – RF]
= + [ – ]
=